Terra Firma has called on hedge fund investor H/2 Capital Partners to accept its proposal to hand over the GP's remaining interest in Four Seasons Health Care for a nominal sum.
HopLop is the first investment from the GP's newly launched special situations strategy
Transaction will see Paragon invest in Questel for a minority stake in the IP consultancy firm
FSI intends to reinvest in Cedacri as a minority shareholder, doubling the capital deployed in 2017
Summa was reportedly eyeing an exit multiple of 15x EBITDA, based on a 2019 figure of €19.6m